published meta-analysis   sensitivity analysis   studies

clarithromycine in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias radiologic improvement (14-day)detailed resultsRashad (CLARI vs SoC), 2021 2.87 [1.56; 5.28] 2.87[1.56; 5.28]Rashad (CLARI vs SoC), 202110%198NAnot evaluable0.55.01.0relative treatment effectwww.metaEvidence.org2024-04-20 03:45 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 894 - roots T: 290